We’re thrilled to announce that mycoBiologics has been selected for Stage I support and added to the INCATE portfolio! The INCATE Selection Committee recognized the potential of our patient-derived human monoclonal antibodies to revolutionize anti-infective drug...
The University of Aberdeen’s mycoBiologics team has received a £400,000 boost from Scottish Enterprise’s High Growth Spin-out Programme (HGSP) to advance its development of life-saving treatments for deadly fungal infections and antibiotic resistance. Led...
A University of Aberdeen spin-out company, mycoBiologics, has been shortlisted for the prestigious Converge 2019 entrepreneurial award in Scotland. Founded by Dr. Fiona Rudkin, mycoBiologics is a pre-incorporation biotech company focused on developing innovative...
